SCHEMBL9708514

SCHEMBL9708514

CCc1nc2c(c(=O)n(C)c(=O)n2CC2CC2)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 3/20 0.43
AGTR2 P50052 3/20 0.43
PDE5A O76074 3/20 0.42
PDE4A P27815 3/20 0.42
PDE4B Q07343 3/20 0.42
PDE4C Q08493 3/20 0.42
PDE4D Q08499 3/20 0.42
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 1/20 0.42
ALDH1A1 P00352 2/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
ADORA1 P30542 1/20 0.39
PDE1B Q01064 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708423 0.94 AGTR1 (0.45) AGTR1AGTR2PDE5APDE4APDE4B
SCHEMBL9708071 0.94 PDE5A (0.49) AGTR1AGTR2PDE5APDE4APDE4B
SCHEMBL9708032 0.92 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL9708622 0.92 PDE5A (0.45) AGTR1AGTR2PDE5APDE4APDE4B
SCHEMBL9709022 0.92 PDE5A (0.46) AGTR1AGTR2PDE5APDE4APDE4B
SCHEMBL9708063 0.92 HSD17B10 (0.40) AGTR1AGTR2PDE5APDE4APDE4B
SCHEMBL9708006 0.91 PDE5A (0.46) AGTR1AGTR2PDE5APDE4APDE4B
SCHEMBL9707433 0.90 PDE5A (0.47) AGTR1AGTR2PDE5APDE4APDE4B
SCHEMBL9707579 0.90 AGTR1 (0.44) AGTR1AGTR2HSD17B10ALOX15ALDH1A1
SCHEMBL9708868 0.90 PDE5A (0.42) AGTR1AGTR2PDE5APDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed